Grace Therapeutics, Inc. (NASDAQ:GRCE), formerly b, announced topline data from its Phase 3 STRIVE-ON safety trial of GTx-104 ...
Hyponatremia commonly occurs in patients with aneurysmal subarachnoid hemorrhage. Two mechanisms have been proposed as causes: syndrome of inappropriate anti-diuretic hormone and cerebral salt ...
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine. New Drug Application (NDA) Submission Expected in the ...
Patients who experience a nonaneurysmal subarachnoid hemorrhage differ from patients who suffer an aneurysmal subarachnoid hemorrhage in initial presentation (including neurological examination ...
Subarachnoid hemorrhage (SAH) is often followed by fever. The rise in brain temperature can lead to ischemic brain injury, hyperemia, exacerbation of cerebral edema, and increased intracranial ...
A subarachnoid hemorrhage was demonstrated on a head CT scan. Investigations. Physical examination, laboratory tests, brain CT scan, brain MRI scan, brain magnetic resonance angiogram, brain ...
Grace Therapeutics Inc. (NASDAQ:GRCE), a $32.85 million market cap biotechnology company whose stock has gained over 37% in the past six months, has announced successful outcomes from its Phase 3 ...
PRINCETON, N.J. - Grace Therapeutics, Inc. (NASDAQ:GRCE), a biopharmaceutical company focused on developing treatments for ...
Financing led by Nantahala Capital and ADAR1 Partners, LP with participation from new and existing healthcare-focused institutional investors$15 ...
Considering taking supplements to treat subarachnoid hemorrhage? Below is a list of common natural remedies used to treat or reduce the symptoms of subarachnoid hemorrhage. Follow the links to ...
A team of doctors including neurologists, interventional radiologists, and neurosurgeons decided to use a minimally invasive approach called endovascular intervention. In this, a specialised device is ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果